(Q38208324)

31 August 2017

title

Mechanisms of isoniazid-induced idiosyncratic liver injury: emerging role of mitochondrial stress (English)

1 reference

31 August 2017

0 references

Urs A Boelsterli

1

1 reference

31 August 2017

Kang Kwang Lee

series ordinal

2

1 reference

31 August 2017

publication date

1 April 2014

1 reference

Journal of Gastroenterology and Hepatology

31 August 2017

published in

1 reference

31 August 2017

volume

29

1 reference

31 August 2017

issue

4

1 reference

31 August 2017

page(s)

678-687

1 reference

The challenge of new drug discovery for tuberculosis

31 August 2017

cites work

1 reference

Toxic hepatitis with isoniazid and rifampin. A meta-analysis

21 January 2018

1 reference

Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.

21 January 2018

1 reference

Hepatotoxicity due to first-line anti-tuberculosis drugs: a five-year experience in a Taiwan medical centre.

21 January 2018

1 reference

Isoniazid: metabolic aspects and toxicological correlates

21 January 2018

1 reference

Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management

21 January 2018

1 reference

Isoniazid-associated hepatitis. Report of an outbreak

21 January 2018

1 reference

Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic

21 January 2018

1 reference

Antituberculosis drug-induced hepatotoxicity: concise up-to-date review

21 January 2018

1 reference

Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging

21 January 2018

1 reference

Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling

21 January 2018

1 reference

Direct oxidation and covalent binding of isoniazid to rodent liver and human hepatic microsomes: humans are more like mice than rats

21 January 2018

1 reference

Isoniazid-induced cell death is precipitated by underlying mitochondrial complex I dysfunction in mouse hepatocytes

21 January 2018

1 reference

Lack of liver injury in Wistar rats treated with the combination of isoniazid and rifampicin

21 January 2018

1 reference

A model of isoniazid-induced hepatotoxicity in rabbits.

21 January 2018

1 reference

In vitro studies on the toxicity of isoniazid in different cell lines

21 January 2018

1 reference

The protective effects of ursodeoxycholic acid on isoniazid plus rifampicin induced liver injury in mice

21 January 2018

1 reference

Protective effects of kaempferol on isoniazid- and rifampicin-induced hepatotoxicity

21 January 2018

1 reference

Rifampicin exacerbates isoniazid-induced toxicity in human but not in rat hepatocytes in tissue-like cultures

21 January 2018

1 reference

Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy

21 January 2018

1 reference

Isoniazid-induced liver injury and immune response in mice

21 January 2018

1 reference

The tuberculosis prodrug isoniazid bound to activating peroxidases

21 January 2018

1 reference

Mechanisms of action of isoniazid

21 January 2018

1 reference

Isoniazid inhibits the heme-based reactivity of Mycobacterium tuberculosis truncated hemoglobin N

21 January 2018

1 reference

Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes

21 January 2018

1 reference

Inhibition of cytochrome P450 enzymes and biochemical aspects of mechanism-based inactivation (MBI).

21 January 2018

1 reference

Does CYP2E1 play a major role in the aggravation of isoniazid toxicity by rifampicin in human hepatocytes?

21 January 2018

1 reference

CYP2E1-dependent elevation of serum cholesterol, triglycerides, and hepatic bile acids by isoniazid

21 January 2018

1 reference

Role of CYP3A in isoniazid metabolism in vivo

21 January 2018

1 reference

Correlations between in vivo and in vitro effects of toxic compounds: Studies with hydrazine

21 January 2018

1 reference

Cellular toxicity of hydrazine in primary rat hepatocytes

21 January 2018

1 reference

A biochemical and NMR spectroscopic study of hydrazine in the isolated rat hepatocyte

21 January 2018

1 reference

Metabonomic investigations into hydrazine toxicity in the rat.

21 January 2018

1 reference

Comparative metabonomics of differential hydrazine toxicity in the rat and mouse

21 January 2018

1 reference

A fresh look at the mechanism of isoniazid-induced hepatotoxicity

21 January 2018

1 reference

Isoniazid and Iproniazid: Activation of Metabolites to Toxic Intermediates in Man and Rat

21 January 2018

1 reference

A novel metabolite of antituberculosis therapy demonstrates host activation of isoniazid and formation of the isoniazid-NAD+ adduct

21 January 2018

1 reference

Effect of isoniazid on preservation of nicotinamide dinucleotide in animal cells.

21 January 2018

1 reference

The toxicological significance of decreased activities of blood alanine and aspartate aminotransferase

21 January 2018

1 reference

Advantages of glutamate dehydrogenase as a blood biomarker of acute hepatic injury in rats

21 January 2018

1 reference

Animal models of idiosyncratic drug reactions

21 January 2018

1 reference

Hydrazide derivatives produce active oxygen species as hydrazine.

21 January 2018

1 reference

Role of hydrazine in isoniazid-induced hepatotoxicity in a hepatocyte inflammation model

21 January 2018

1 reference

1-Aminobenzotriazole, a known cytochrome P450 inhibitor, is a substrate and inhibitor of N-acetyltransferase

21 January 2018

1 reference

Hepatocyte growth factor protects against isoniazid/rifampicin-induced oxidative liver damage.

21 January 2018

1 reference

Protective effects of metallothionein on isoniazid and rifampicin-induced hepatotoxicity in mice

21 January 2018

1 reference

Isoniazid suppresses antioxidant response element activities and impairs adipogenesis in mouse and human preadipocytes

21 January 2018

1 reference

Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies

21 January 2018

1 reference

Free radical-induced megamitochondria formation and apoptosis.

21 January 2018

1 reference

Liver toxicity of antiretroviral drugs

21 January 2018

1 reference

Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells

21 January 2018

1 reference

Compromising mitochondrial function with the antiretroviral drug efavirenz induces cell survival-promoting autophagy

21 January 2018

1 reference

Efavirenz and 8-hydroxyefavirenz induce cell death via a JNK- and BimEL-dependent mechanism in primary human hepatocytes

21 January 2018

1 reference

Profile of stress and toxicity gene expression in human hepatic cells treated with Efavirenz

21 January 2018

1 reference

ER stress in human hepatic cells treated with Efavirenz: mitochondria again

21 January 2018

1 reference

Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India

21 January 2018

1 reference

Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis

21 January 2018

1 reference

Mechanisms of mitochondrial targeting of cytochrome P450 2E1: physiopathological role in liver injury and obesity

21 January 2018

1 reference

GSTM1 and GSTT1 genetic polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity: an updated meta-analysis

21 January 2018

1 reference

Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment

21 January 2018

1 reference

Host-gut microbiota metabolic interactions

21 January 2018

1 reference

Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.

21 January 2018

1 reference

Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B.

21 January 2018

1 reference

Enhanced oxidative stress and increased mitochondrial mass during efavirenz-induced apoptosis in human hepatic cells

21 January 2018

1 reference

Is It Time for a Metagenomic Basis of Therapeutics?

21 January 2018

1 reference

Proton NMR spectroscopic studies on the metabolism and biochemical effects of hydrazine in vivo

21 January 2018

1 reference

Gut microbiome modulates the toxicity of hydrazine: a metabonomic study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JGH.12516

1 reference

31 August 2017

1 reference